$EXEL EXELIXIS, INC. Insider Trading
Get free email notifications about insider trading in EXELIXIS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EXELIXIS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in EXELIXIS, INC. for free.
IRS Number: 043257395
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: EXEL
Company Address: 1851 HARBOR BAY PARKWAY ALAMEDA 94502
Phone number: 650-837-7000
Former name: EXELIXIS PHARMACEUTICALS INC, date of change: 2000-01-06
Former name: EXELIXIS INC, date of change: 2000-02-07
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of COMETRIQ, CABOMETYX, COTELLIC, and MINNEBRO. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Market Capitalization: $6.19B
Prev close: $20.57
Average Daily Volume: 5,987,500
Days Low: $19.98
Year Low: $3.55
Year High: $22.02
EXELIXIS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | A | 22.48 | 16,598 | 373,123 | 16,598 | |
| May 28 2021 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Grant | A | 0.00 | 8,299 | 0 | 74,414 | 66.1 K to 74.4 K (+12.55 %) |
| May 28 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 22.48 | 33,549 | 754,182 | 33,549 | |
| May 28 2021 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Grant | A | 0.00 | 16,424 | 0 | 173,614 | 157.2 K to 173.6 K (+10.45 %) |
| May 18 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Sell | S | 24.73 | 14,593 | 360,885 | 280,994 | 295.6 K to 281 K (-4.94 %) |
| May 18 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Payment of Exercise | F | 25.56 | 3,026 | 77,345 | 295,587 | 298.6 K to 295.6 K (-1.01 %) |
| May 17 2021 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Sell | S | 24.97 | 40,802 | 1,018,826 | 157,190 | 198 K to 157.2 K (-20.61 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 4.20 | 50,000 | 210,000 | 100,000 | |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 19,722 | 0 | 1,038,789 | 1 M to 1 M (+1.94 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 19,722 | 0 | 491,813 | 511.5 K to 491.8 K (-3.86 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 25.16 | 30,278 | 761,794 | 511,535 | 541.8 K to 511.5 K (-5.59 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 4.20 | 50,000 | 210,000 | 541,813 | 491.8 K to 541.8 K (+10.17 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 40,616 | 0 | 1,019,067 | 1.1 M to 1 M (-3.83 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.90 | 100,000 | 190,000 | 150,000 | |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 25.38 | 100,000 | 2,538,000 | 614,078 | 714.1 K to 614.1 K (-14.00 %) |